Predominant porB1A and porB1B genotypes and correlation of gene mutations with drug resistance in Neisseria gonorrhoeae isolates in Eastern China by Sun, Aihua et al.
RESEARCH ARTICLE Open Access
Predominant porB1A and porB1B genotypes and
correlation of gene mutations with drug
resistance in Neisseria gonorrhoeae isolates in
Eastern China
Aihua Sun
1,2,3, Xingli Fan
2,Y eG u
4, Peng Du
1,2,3, Renxian Tang
5, Yafei Mao
1,3, Xuai Lin
1,3, Jie Yan
1,3*
Abstract
Background: Variations of porB1A and porB1B genes and their serotypes exist in Neisseria gonorrhoeae isolates from
different geographical areas, and some site mutations in the porB1B gene correlate with drug resistance.
Methods: The b-lactamase production of N. gonorrhoeae isolates was determined by paper acidometric test and
nitrocefin discs. The porB1A and porB1B genes of 315 non-penicillinase-producting N. gonorrhoeae (non-PPNG)
strains were amplified by PCR for sequencing to determine serotypes and site mutations. A duplex PCR was
designed to simultaneously detect both porB1A and porB1B genes. Penicillin and tetracycline resistance was
assessed by an in vitro drug sensitivity test.
Results: Of the N. gonorrhoeae isolates, 31.1% tested positive for porB1A and 68.9% for porB1B genes. All the 98
porB1A
+ isolates belonging to IA6 serotype with either no mutation at the 120 and 121 sites (88.8%) or a D120G
(11.2%) mutation and were no resistance to both penicillin and tetracycline. Among the 217 porB1B
+ isolates,
26.7%, 22.6% and 11.5% belonged to IB3, IB3/6 and IB4 serotypes, respectively. Particularly, two novel chimeric
serotypes, IB3/6-IB2 and IB2-IB4-IB2, were found in 77 and 8 porB1B
+ isolates. Two hundred and twelve (97.7%) of
the porB1B
+ isolates were presented G120 and/or A121 mutations with 163 (76.9%) at both sites. Interestingly,
within the 77 porB1B
+ isolates belonging to IB3/6-IB2 serotype, 15 were discovered to possess novel deletions at
both A121 and N122 sites. All the replacement mutations at these sites in PorB1B were correlated with resistance
and the deletion mutation showed the highest resistance.
Conclusion: N. gonorrhoeae isolates circulating in Eastern China include a sole PorB1A serotype (IA6) and five
PorB1B serotypes. Multiple mutations in porB1B genes, including novel A121 and N122 deletions, are correlated
with high levels of penicillin and tetracycline resistance.
Background
G o n o r r h o e ac a u s e db yi n f e c t i o nw i t hNeisseria gonor-
rhoeae is a global sexually transmitted disease. In Chi-
nese populations, gonorrhoea is the most common
sexually transmitted disease which causes a serious pub-
lic health problem [1-5].
The outer membrane of N. gonorrhoeae bears many
proteins such as porins that have been studied in
considerable detail [6-10]. Gonococcal porins are a
group of outer membrane proteins that occur in large
amounts on the surface [11-17]. PorB1A and PorB1B
porins, which have 65-80% amino acid identity, share
60% of the total gonococcal porin proteins [12,18].
PorB1A and PorB1B are encoded by the same allele and
any particular N. gonorrhoeae strain expresses either
PorB1A or PorB1B [12,19,20]. PorB1A is present in
10-30% of N. gonorrhoeae isolates, while PorB1B occurs
in 70-90% [21,22]. PorB1A and PorB1B are the serotyp-
ing basis of N. gonorrhoeae and mutations are more
common in porB1B gene than in porB1A gene
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any medium, provided the original work is properly cited.[19,22,23]. Many investigations revealed geographical
diversity of the predominant porB1A and porB1B geno-
types isolates in different areas [22,24-27]. Therefore,
determination of porB1A and porB1B genotype distribu-
tion in N. gonorrhoeae isolates in different areas is very
important for providing a high index of discrimination
of different gonococcal strains, identifying the circulat-
ing strains and predominant serotypes, and tracking
strain transmission in sexual contacts [28-32].
N. gonorrhoeae easily develops resistance to many
antibiotics. Previous studies demonstrated that the
replacement mutations at the 120 and 121 sites in
PorB1B protein enable these strains to increase their
resistance to penicillin and tetracycline [33,34]. How-
ever, replacement mutations at the 120 and 121 sites in
PorB1A make little contribution to resistance against
the two antibiotics [9,19]. Thus, identification of the two
resistance-related site mutations in PorB1B sequences of
N. gonorrhoeae isolates, and determination of the corre-
lation between the site mutations and drug resistance
are important for chemotherapy of gonorrhoea in the
clinical setting. In the present study, we established a
duplex polymerase chain reaction (PCR) system to
rapidly confirm the porB1A and porB1B genes in N.
gonorrhoeae isolates from Chinese patients. And the pre-
dominant serotypes based on porB1A and porB1B geno-
typing of the isolates circulating in Eastern China were
determined by sequence analysis. Particularly, mutation
at the 120 and 121 sites in PorB1B sequence from the
non-penicillinase-producting N. gonorrhoeae (non-
PPNG) isolates, as well as the correlation between the
mutation patterns and the resistance to penicillin and
tetracycline, were investigated.
Methods
Ethics statement
This research was conducted in accordance with the
Declaration of Helsinki, and informed consent was
obtained from all patients in this study for collection of
clinical specimens to isolate N. gonorrhoeae strains,
according to a protocol approved by the Ethics Commit-
tee of Zhejiang University.
Bacterial strains and growth
The clinical N. gonorrhoeae strains were isolated from
gonorrhea patients from 2005 to 2008 by the clinical
laboratories of several hospitals in Zhejiang and Jiangsu
provinces, China. All the gonococcal isolates were first
identified by the hospital laboratories and subsequently
rechecked by our laboratory using microscopy after
Gram staining plus oxidase, catalase, and carbohydrate
degradation tests [35]. The gonococci were cultured on
GCB blood agar plates (bioMérieux, Co., Ltd, Shanghai,
China) at 37°C in the presence of 5% CO2 for 24 h.
Staphylococcus aureus ATCC25923, Staphylococcus
epidermidis ATCC12228, Streptococcus pyogenes
ATCC29212, Escherichia coli ATCC25922, Pseudomonas
aeruginosa ATCC27543, Klebsiella pneumoniae
ATCC700603, Serratia marcescens ATCC14041, Entero-
bacter cloacae ATCC13047 and Proteus mirabilis
ATCC25933 were used to determine the specificity of
duplex PCR, and were provided by the Chinese National
Institute for Control of Pharmaceutical and Biological
Products, and cultured in MH broth (bioMrieux) at
37°C for 24 h.
b-lactamase detection
Paper acidometric test was applied by the clinical
laboratories of hospitals to primarily detect the b-lacta-
mase production of gonococcal isolates [5], and subse-
quently BBL(tm) Cefinase(tm) Paper Disc (BD, USA)
based on nitrocefin coloration was used by our labora-
tory to further determine the production of gonococcal
b-lactamase [36]. Among all the N. gonorrhoeae isolates,
315 strains were identified as non-PPNG that were used
in this study.
DNA preparation
The gonococci and the other bacteria were collected by
centrifugation and washed twice with phosphate buf-
fered saline (PBS). Genomic DNA of each precipitated
strain was extracted with a bacterial genomic DNA
extraction kit (BioColor Inc., Shanghai, China) and then
dissolved in TE buffer for detecting the DNA concentra-
tion with ultraviolet (UV) spectrophotometry [37].
Amplification of entire porB1A and porB1B genes
One pair of forward (porB1A/1B-F) and reverse
(porB1A/1B-R) primers was used to amplify both the
entire porB1A and porB1B genes in genomic DNA of
the gonococcal isolates because they have the same
nucleotide sequences at the 5’ and 3’ terminals (Table 1)
[19,38,39]. A High Fidelity PCR Kit (TaKaRa Co., Ltd,
Dalian, China), in which a Taq-Pfu mixture was used as
the DNA polymerase, was used to amplify the two target
genes. PCR was initiated by incubation at 94°C for 5
min, followed by 30 cycles at 94°C for 30 s, 54°C for 30
s and 72°C for 90 s to amplify each the two genes, and
then incubation at 72°C for 10 min. The products in
1.5% ethidium bromide pre-stained agarose gel after
electrophoresis were observed under UV light. The tar-
get products are predicted to be 981 bp (entire porB1A
gene) and 1044 bp (entire porB1B gene).
Sequencing and genotyping
The PCR products of the entire porB1A and porB1B
genes from the N. gonorrhoeae isolates were purified
with a PCR products purification kit (BioColor) and
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nant pMD-18-T
porB1A and pMD-18-T
porB1B with a T-A
cloning kit (TaKaRa). The inserted target segments in
recombinant plasmids were sequenced using the double-
stranded dideoxy chain termination method by Invitro-
gen Co., Ltd, Shanghai, China. The obtained sequencing
data were analyzed as well as compared to the
sequences of PorB1A and PorB1B serotypes published
in GenBank using Clustalx software.
Duplex PCR
The sequencing data of porB1A and porB1B genes from
the N. gonorrhoeae isolates showed that these genes have
over 80% identity at the 5’ terminal sequences (1-240 bp
segments in both genes) and approximately 90% identity
at the 3’ terminal sequences (714-981 bp segment in
porB1A gene and 777-1044 bp segment in porB1B gene).
However, a 63 bp segment in the middle region of porB1B
gene that was absent in porB1A gene enabled us to design
a specific forward primer only for detecting the porB1B
gene. Thus, by using two different forward primers (20
pmol porB1A/1B-D-F1 and 20 pmol porB1A/1B-D-F2)
and one common reverse primer (20 pmol porB1A/1B-D-
R) (Table 1), a duplex PCR system was established to
simultaneously detect the porB1A and porB1B genes in
the gonococcal isolates. The total volume per duplex PCR
was a 50 μl mixture in which 100 ng DNA template was
used. The PCR was initiated by incubation at 94°C for 3
min, followed by 35 cycles at 94°C for 30 s, 54°C for 30 s
and 72°C for 60 s, and then incubation at 72°C for 7 min.
In agarose gel, the porB1A gene product presented a 520
bp fragment and the porB1B g e n ep r o d u c ts h o w e dt w o
fragments of 201 bp and 583 bp.
Drug sensitivity test
Susceptibility of the N. gonorrhoeae isolates to penicillin
(bioMérieux) and tetracycline (bioMérieux) was assessed
on GC agar plates (bioMérieux) by the standard propor-
tion method [33,34]. Briefly, each freshly cultured isolate
was suspended in GC broth to a density of 10
4/μl, and 5
μl of gonococcal suspension was spotted onto GC agar
plates containing increasing concentrations of penicillin
or tetracycline (0.03, 0.06, 0.12, 0.25, 0.5, 1, 2, 4, 8, 16,
32, 64 and 128 μg/ml). After inoculation, the plates
were incubated at 37°C in 5% CO2 for 24 h. The mini-
mal inhibitory concentration (MIC) was defined as the
minimum concentration of antibiotic at which no more
than 5 colonies were observed after incubation. A MIC
value ≥2 mg/L was considered as resistance to the anti-
biotics [40,41]. This test was repeated as three indepen-
dent experiments.
Results
Sensitivity and specificity of duplex PCR
In our duplex PCR, porB1A and porB1B gene segments
were effectually amplified when using a DNA concentra-
tion of N. gonorrhoeae as low as 10 ng, and negative
results were shown when using 10 to 500 ng DNA tem-
plates of S.aureus ATCC25923, S. epidermidis
ATCC12228, S. pyogenes ATCC29212, E. coli
ATCC25922, P. aeruginosa ATCC27543, K. pneumoniae
ATCC700603, S. marcescens ATCC14041, E. cloacae
ATCC13047 and P. mirabilis ATCC25933.
Distribution of porB1A and porB1B genes in N.
gonorrhoeae isolates
Of the 315 N. gonorrhoeae isolates tested, 31.1% (98/315)
and 68.9% (217/315) were found by separate PCR to pos-
sess porB1A and porB1B genes, respectively. The duplex
PCR established in this study accurately distinguished the
porB1A and porB1B genes (Figure 1), and presented the
same positive rates for porB1A (31.1%) and porB1B
(68.9%) genes in the same gonococcal isolates.
porB1A serotype in N. gonorrhoeae isolates
Compared to the porB1A sequences belonging to differ-
ent PorB1A serotypes in GenBank, all the 98 porB1A
+
isolates had 99.47% to 100% nucleotide sequence iden-
tity and 99.04% to 100% amino acid sequence identity to
the IA-6 serotype (GenBank accession No.: L19962, IA-6
serotype) (Figure 2) [19].
porB1B serotypes in N. gonorrhoeae isolates
Compared to the reported porB1B sequences belonging
to different serotypes in GenBank [31,32], 26.7% (58/
217), 22.6% (49/217) and 11.5% (25/217) of the 217
porB1B
+ gonococcal isolates belonged to serotypes IB3,
IB3/6, and IB4, respectively. Some (35.5%; 77/217) of
the porB1B
+ isolates were chimeras of the IB3/6 and IB2
serotypes (IB3/6-IB2 serotype) in which about half the
sequences from the 5’ terminal were like the IB3/6
Table 1 Primer sequences used in PCR for amplifying
porB1A and porB1B genes
Primers Sequences (5’ to 3’)* Products and sizes
porB1A/
1B
F:
ATGAAAAAATCCCTGATTGCC
981 bp for entire porB1A gene,
and 1044 bp for entire porB1B
gene
R:
TTAGAATTTGTGGCGCAGAAC
porB1A/
1B-D
F1:
GCCATTTGGCAGTTGGAACA
520 bp for partial sequence of
porB1A gene, and 201 bp and
583 bp for partial sequence of
porB1B gene
F2:
GATACGGCGAAGGCACTAAA
R:
CTTCGGTTTGAGAGTTGTGC
* F: forward primer, R: reverse primer
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3.7% (8/217) of the porB1B
+ isolates were chimeras of
the IB2 and IB4 serotypes (IB2-IB4-IB2 serotype) in
which the sequence in the middle was like the IB4 sero-
type but those at the two terminals were like the IB2
serotype (Figure 3).
Mutations at the 120 and 121 sites in PorB1A and PorB1B
Mutations at the 120 and 121 sites in PorB1A and PorB1B
sequences from all 315 N. gonorrhoeae isolates are listed
in Table 2. In the 98 porB1A
+ isolates, 88.8% (87/98) had
D120 and G121 in the PorB1A sequences which is identi-
cal to those in the reported PorB1A sequence belonging to
the IA-6 serotype (GenBank accession No.: L19962) [19],
and the remaining 11 porB1A
+ isolates had a D120G
mutation alone (Figure 2). In the 217 porB1B
+ gonococcal
i s o l a t e s ,o n l y2 . 3 %( 5 / 2 1 7 ,t h r e eb e l o n g i n gt ot h eI B 3 / 6
serotype and two belonging to the IB3 serotype) had no
mutation at the 120 and 121 sites (G120 and A121), while
97.7% (212/217) showed various mutations at the sites.
Particularly, in the 212 porB1B
+ isolates with the site
mutations, 15 isolates (6.9%, 15/217) belonging to the IB3/
6-IB2 serotype had a deletion of the amino acid residues
at both 121 and 122 sites (Figure 3).
Correlation between resistance and mutations at 120 and
121 sites in PorB1A and PorB1B
The MICs of penicillin and tetracycline for all the 98
porB1A
+ gonococcal isolates were 0.06-1 mg/L (<2 mg/
L), while the MICs for both antibiotics in the 5 porB1B
+
gonococcal isolates with no mutations at the 120 and
121 sites in PorB1B were 0.12-0.5 mg/L (<2 mg/L).
However, the MICs of penicillin and tetracycline in the
197 porB1B
+ isolates with replacement mutations at the
120 and/or 121 sites were 2-8 mg/L and 2-16 mg/L,
respectively, and the 15 porB1B
+ isolates with deletion
mutations at both the 121 and 122 sites had the highest
resistance to penicillin (MICs = 4-8 mg/L) and tetracy-
cline (both MICs = 4-16 mg/L) (Table 3). According to
the MIC value (≥2 mg/L) that defines resistance to peni-
cillin and tetracycline, all the porB1A
+ isolates and the 5
porB1B
+ isolates without site mutations were no resis-
tance to both antibiotics, while all the remaining 212
porB1B
+ isolates with different site mutations were peni-
cillin and tetracycline resistant.
Discussion
The porins of N. gonorrhoea stimulate the host immune
system to produce specific antibodies which activate the
complement system and promote phagocytosis to elimi-
nate the invading gonococci [9,42]. Furthermore, gono-
coccal PorB1A and PorB1B are closely associated with
transmission of gonorrhea [38,42], and mutations at the
120 and 121 sites in PorB1B are related to drug resis-
tance [9,19,33,34]. Thus, determination of the predomi-
nance of PorB1A and PorB1B serotypes and drug
resistance-associated mutations in the porB1B gene in
different areas is important for serological diagnosis and
chemotherapy of gonorrhoea.
For rapid and convenient discrimination of porB1A
and porB1B genes in N. gonorrhoeae isolates, we
designed a duplex PCR system by which both genes
were simultaneously detectable. The results indicated
that the duplex PCR accurately recognizes the porB1A
and porB1B genes in all the 315 tested isolates with
high sensitivity and specificity. By using the duplex PCR,
we found 31.1% of the 315 isolates tested were positive
for the porB1A gene and the porB1B gene was detect-
able in 68.9% of the isolates. This porB1A
+ and porB1B
+
proportion in N. gonorrhoeae isolates is close to that of
previous reports [21,22].
The gonococcal porB1B gene differs from the porB1A
gene in having many more mutations in its sequence
[19,38,39]. Among the 217 porB1B
+ isolates in this
study, 77 (35.5%), 58 (26.7%), and 49 (22.6%) isolates
belonged to the IB3/6-IB2, IB3 and IB3/6 serotypes, and
only 25 (11.5%) and 8 (3.7%) referred to the IB4 and
IB2-IB4-IB2 serotypes, respectively. These data indicate
that the predominant serotypes of porB1B
+ N. gonor-
rhoeae in Eastern China are IB3/6-IB2, IB3 and IB3/6
(84.8%, 184/217), which quite differs from the IB2, IB4
and IB3 reported as the predominant serotypes in
nations in Europe and North America [19,22-24]. Bash
Figure 1 Amplicons of entire or partial porB1A and porB1B
genes. Note: Lane M: DNA marker (BioColor); Lanes 1 and 2:
amplicons of entire porB1A gene (981 bp) and porB1B gene (1044
bp), respectively; Lanes 3 and 4: amplicons of partial porB1A gene
(520 bp) and partial porB1B gene (583 bp and 201 bp) by duplex
PCR, respectively; Lane 5: blank control.
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a high recombinant mutation frequency compared to
the porB1A gene [43]. In our study, two novel recombi-
nant mutations formed IB3/6-IB2 and IB2-IB4-IB2 chi-
meric serotypes, which also indicates a high frequency
of recombination among different gonococcal porB1B
genes. There have been reports of N. gonorrhoeae strains
that react to both PorB1A and PorB1B antibodies, rais-
ing the possibility of mosaicism between porB1A and
porB1B alleles [44,45]. However, no such mosaicism was
found in all the N. gonorrhoeae isolates tested in this
study.
Olesky et al. (2002) used the site mutation technique
to generate mutants at the 120 and 121 sites in PorB1B,
and found stronger resistance to penicillin and tetracy-
cline in the G120K, G120D/A121D, G120K/A121R and
G120P/A121P mutants [46]. Among the 217 porB1B
+
isolates in this study, only five had no mutations at the
120 and 121 sites, while the other 212 had various
mutations at these sites, in which 76.9% (163/212) had
double-site mutations (G120K/A120D, G120K/A121G
and G120N/A121D in 135, 19 and 9 isolates). All the
212 porB1B
+ isolates had a mutation at the G120 site
replaced with lysine (K) (76.9%, 163/212), aspartate (D)
Figure 2 Amino acid sequences from porB1A genes of N. gonorrhoeae isolates. Note: (IA6): reported amino acid sequence of IA6 serotype
(GenBank accession No: L19962); (1) and (2): PorB1A sequences from 56 and 23 gonococcal isolates, respectively; (3) to (5): PorB1A sequences
from 8 gonococcal isolates; (6) PorB1A sequences from 11 gonococcal isolates. Underlined areas indicate positions of primers.
Sun et al. BMC Infectious Diseases 2010, 10:323
http://www.biomedcentral.com/1471-2334/10/323
Page 5 of 9Figure 3 Amino acid sequences from porB1B genes of N. gonorrhoeae strains. Note: (IB3), (IB3/6), (IB2) and (IB4): reported PorB1B
sequences belonging to serotypes IB3 (GenBank accession No: U75639), IB3/6 (GenBank accession No: U75641), IB2 (GenBank No: U75640) and
IB4 (GenBank No: AF090797), respectively; (1): PorB1B sequence from 58 gonococcal isolates referring to IB3 serotype; (2): PorB1B sequence from
49 gonococcal isolates referring to IB3/6 serotype (D means the 27 isolates with A121D mutation, the 19 isolates with A121G mutation and the
remaining 3 isolates with no mutation at the A121 site); (3): PorB1B sequence from 62 gonococcal isolates referring to IB3/6-IB2 chimeric
serotype without A121 and N122 deletion (K means the 53 strains with G120K mutation and the remaining 9 strains with G120N mutation); (4):
PorB1B sequence from 15 gonococcal isolates referring to IB3/6-IB2 chimeric serotype with A121 and N122 deletions; (5): PorB1B sequence from
25 gonococcal isolates referring to IB4 serotype; (6): PorB1B sequence from 8 gonococcal isolates referring to IB2-IB4-IB2 chimeric serotype.
Underlined areas indicate the positions of primers. The signal “/” means lack of the amino acid residue.
Sun et al. BMC Infectious Diseases 2010, 10:323
http://www.biomedcentral.com/1471-2334/10/323
Page 6 of 9(11.8%, 25/212) or asparagine (N) (11.3%, 24/212). On
the other hand, 76.9% of the 212 porB1B
+ strains had a
mutation at the A121 site replaced with aspartate (D)
(88.3%, 144/163) or glycine (G) (11.7%, 19/163). How-
ever, the G120R, G120P, A121H and A121P mutations
described by Olesky et al were not found, suggesting
differences in the amino acids replacement by natural
and artificial mutations. Particularly, in this study we
found that 15 gonococcal isolates had A121 and N122
deletion mutations in PorB1Bt h a th a dn o tp r e v i o u s l y
been reported.
Many previous data revealed that plasmid-mediated
resistance of N. gonorrhoeae confer the very high MICs
of penicillinand tetracycline [47-49], while chromoso-
mally mediated resistance such as the site mutations at
G120 or A121 in gonococcal PorB1B contributes to the
moderate higher MICs of the two antibiotics [33,34].
According to our drug sensitivity tests for the non-
PPNG isolates, the G120K/A121D, G120K/A121G,
G120N/A121D, G120D and G120K natural porB1B
mutants also had stronger resistance to penicillin and
tetracycline than porB1B
+ isolates with no G120 and
A121 mutations (Table 3). Interestingly, the 15 porB1B
+
isolates with A121 and N122 deletions had the highest
MICs, which hints at a greater influence of the A121
deletion on resistance than any of the replacement
mutations. This resistance relating to chromosomally-
mediated site mutations in PorB1B has been shown in
many previous reports [33,46,50-52]. However, in these
reports the PorB1B mutation-associated resistance only
noted MICs of penicillin and tetracycline in the range of
2-8 μg/ml. Previous data revealed that site mutations in
the penA, mtrR, ponA,a n drpsJ genes also participate in
chromosomally-mediated gonococcal resistance to peni-
cillin and tetracycline [47,53-55]. Thus, synergistic
action of site mutations in multiple chromosomal genes
associated with resistance in N. gonorrhoeae isolates is
an important subject for investigation. Such action may
be responsible for the high resistance to both antibiotics
found in this study.
We found that all the tested porB1A
+ gonococcal iso-
lates were no resistance to both penicillin and tetracy-
cline, whereas 97.7% (212/217) of the porB1B
+ isolates
had site mutation-based resistance in the PorB1B
sequences. The high proportion (100%) of resistance-
associated mutations at the 120 and 121 sites in PorB1B
of N. gonorrhoeae isolates from other Chinese areas has
also been reported [51,52,56]. Thus, the duplex PCR
established in this study for rapid identification of
porB1A
+ and porB1B
+ gonococci provides a useful tool
for selecting antibiotics to treat gonorrhea in China.
Conclusions
The duplex PCR system we designed simultaneously
recognizes porB1A and porB1B genes in N. gonorrhoeae
isolates with high sensitivity and specificity. porB1B
+ N.
Table 2 G120 and A121 mutations in PorB1A and PorB1B of N. gonorrhoeae isolates*
Serotypes Cases (n) Site mutation patterns (n)
G120K/A121D G120K/A121G G120N/A121D G120D/A121G G120D G120K G120N A121G
IB3 56 56 0 0 0 0 0 0 0
IB3/6 46 27 19 0 0 0 0 0 0
IB4 25 0 0 0 0 25 0 0 0
IB3/6-IB2 62 44 0 9 0 0 9 0 0
IB3/6-IB2
# 15 0 0 0 0 0 0 15 0
IB2-IB4-IB2 8 8 0 0 0 0 0 0 0
IA6 98 0 0 0 87 0 0 0 11
Total 310 135 19 9 87 25 9 15 11
*: 5 isolates (3 for IB3/6 and 2 for IB3 serotypes) without G120 and A121 mutations not included. G, K, A, D and N indicate glycine, lysine, aspartic acid and
asparagine, respectively.
#: isolates with deletions of both A121 and N122.
Table 3 MICs of penicillin and tetracycline for N.
gonorrhoeae isolates
Site mutations* Serotypes Cases
(n)
MICs (mg/L)
Penicillin Tetracycline
G120K/A121D IB3 56 2-4 2-8
IB3/6 27 2-4 2-8
IB3/6-IB2 44 2-4 2-8
IB2-IB4-IB2 8 2-4 2-4
G120K/A121G IB3/6 19 2-4 2-8
G120N/A121D IB3/6-IB2 9 2 2-4
G120D IB4 25 2-4 2-8
G120K IB3/6-IB2 9 2-4 2-8
G120N/A121 and N122
deletion
IB3/6-IB2 15 4-8 4-16
G120G/A121A IB3/6 3 0.12 0.25
IB3 2 0.25 0.25
D120D/G121G IA6 87 0.06-0.5 0.06-0.5
D120G/G121G IA6 11 0.12-0.25 0.12-1
*: G, K, A, D and N indicate glycine, lysine, aspartic acid and asparagine,
respectively.
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Page 7 of 9gonorrhoeae is the predominant genotype in Eastern
China. All the porB1A
+ isolates had the conserved
porB1A gene sequence belonging to the IA6 serotype
alone. However, the porB1B
+ isolates had high site
mutations in the porB1B sequence that resulted in five
PorB1B serotypes. All the porB1A
+ isolates were no
resistance to both penicillin and tetracycline. However,
multiple penicillin and tetracycline resistance-related
mutations such as G120K/A121D, G120K/A121G and
G120N/A121D occurred in PorB1B isolates. A novel
mutation due to deletion of both A121 and N122 in
PorB1B is correlated with high resistance to penicillin
and tetracycline.
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